App-Quantinova.ai

Diagnosis and Treatment Trends of Cerebral Venous Thrombosis in a Large Observational Cohort

Saif Bushnaq - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Internal Carotid Artery Angle and the Risk of Floating Mural Thrombosis in Acute Cerebral Infarction Patients

Yuko Abe - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Effects of ONO-8610539, an Injectable Small-Molecule Inhibitor of Blood Coagulation Factor XIa, on Rabbit Photothrombotic Stroke Model, Comparison With Tissue Plasminogen Activator

Shinya Sakimoto - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ONO8610539

Quality of Stroke Care Between 2008 and 2014 in Korea, Analysis of the Nationwide Acute Stroke Quality Assessment Program

Hong-Kyun Park - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Use of Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis

James A Giles - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Anticoagulation Therapy in Patients With Cancer Related Stroke and High Risk of Bleeding

Jaechun Hwang - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Diagnostic Yield of MRI/MRA in 400 Patients With Spontaneous Intracerebral Hemorrhage

Nohra Chalouhi - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Safety of Heparin for Prophylaxis of Venous Thromboembolism in Oral Anticoagulation-Associated Intracerebral Hemorrhage

Jochen A Sembill - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Risk Factors for Intracranial Hemorrhage in Cerebral Venous Thrombosis

Khaled Afifi - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Early Mobilization After 12 Hours Post Thrombolysis is Feasible and Safe in Minor Stroke Patients

Tricia Tubergen - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Sex-Related Differences in Neonatal Stroke, International Maternal Newborn Stroke Registry

So Lee - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Association of Pre-Stroke Statin Use With Initial Severity and In-Hospital Outcomes After First-Ever Acute Ischemic Stroke Among Patients With Atrial Fibrillation

Lixia Zong - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Characteristics and Outcomes in Patients With Atrial Fibrillation (af) Receiving Direct Oral Anticoagulants (doacs) in off-Label Dose

Mary S Vaughan Sarrazin - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

Elevated High-Sensitivity C-Reactive Protein and Serum Claudin-5 are Associated With Venous Infarction and/or Severity in Acute/Subacute Cerebral Venous Thrombosis

Jian Gang Duan - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Occlusal-HP Topical

Mechanical Thrombectomy for Cerebral Venous Thrombosis is Associated With Increased Inpatient Mortality, Outcomes From the Nationwide Inpatient Sample

Peggy Nguyen - International Stroke Conference (ISC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Perioperative Outcomes of Aspirin Use in Radical Prostatectomy

Matthew D. Ingham - New England Section of the American Urological Association (NEAUA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Aspirin

Perioperative Outcomes of Aspirin Use in Partial Nephrectomy

Matthew D. Ingham - New England Section of the American Urological Association (NEAUA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy

Philip J. Cheng - New England Section of the American Urological Association (NEAUA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk of Post-Operative Venous Thromboembolism in Urethroplasty

Matthew J. Moynihan - New England Section of the American Urological Association (NEAUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Optimizing the Threshold for Pelvic Lymph Node Dissection in the Contemporary Surgical Management of Prostate Cancer

Danielle A. Velez - New England Section of the American Urological Association (NEAUA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

7277 Abstracts